Questionnaire

1. The concept of TIA has changed from time-based to imaging-dependent determination, whereby TIA is diagnosed in a patient with transient ischaemic symptoms and no evidence of infarction.

2. The aetiology of TIA in patients without a remaining neurological deficit can be determined with the use of:

3. In terms of risk factors for the development and recurrence of AF, an ESC-recommended therapy for the management of heart failure with reduced or preserved ejection fraction is a:

4. Anticoagulation is thought to be warranted when AF is present for longer than:

5. Gender is no longer considered a determinant in the risk for stroke and so oral anticoagulation is recommended for all patients with a (non-sex) CHA₂DS₂-VA score:

6. To avoid stroke and thromboembolism in the patient with AF, the ESC recommends using a DOAC as first-line anticoagulation therapy except in patients with:

7. Population-based screening for AF has demonstrated:

8. The number-needed-to-treat for a good neurological outcome of mechanical thrombectomy for LVO is:

9. Patients who present with sequential stenoses or occlusion have poorer thrombectomy outcomes.

10. Endovascular treatment for acute ischaemic stroke is recommended when the ASPECT score is: